Tbg Diagnostics Ltd (TDL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 06-2016 | |
| Sales | 4,606 | 3,346 | 3,153 | 4,025 | 3,206 |
| Cost of Goods | 1,949 | 823 | 362 | 1,022 | 1,057 |
| Gross Profit | 2,657 | 2,523 | 2,791 | 3,003 | 2,149 |
| Operating Expenses | 6,031 | 6,531 | 5,521 | 8,032 | 6,129 |
| Operating Income | -3,374 | -4,008 | -2,730 | -5,029 | -3,980 |
| Interest Expense | 49 | N/A | N/A | 12 | N/A |
| Other Income | -126 | -7,214 | 198 | 1,181 | 533 |
| Pre-tax Income | -3,549 | -11,222 | -2,532 | -3,860 | -3,447 |
| Net Income Continuous | -3,549 | -11,222 | -2,532 | -3,860 | -3,447 |
| Net Income Discontinuous | N/A | 11,842 | -1,862 | -2,688 | -8,930 |
| Minority Interests | N/A | 145 | 244 | N/A | N/A |
| Net Income | $-3,549 | $765 | $-4,150 | $-6,548 | $-12,378 |
| EPS Basic Total Ops | -0.02 | 0.00 | -0.02 | -0.03 | -0.07 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.01 | -0.02 | -0.02 |
| EPS Basic Discontinuous Ops | 0.00 | 0.05 | -0.01 | -0.01 | -0.05 |
| EPS Diluted Total Ops | -0.02 | 0.00 | -0.02 | -0.03 | -0.07 |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.05 | -0.01 | -0.01 | -0.05 |
| EBITDA(a) | $-3,500 | $-4,008 | $-2,730 | $-3,848 | $-3,980 |